CN1110150A - 一种加味双黄连药剂及其制备方法 - Google Patents
一种加味双黄连药剂及其制备方法 Download PDFInfo
- Publication number
- CN1110150A CN1110150A CN94103391A CN94103391A CN1110150A CN 1110150 A CN1110150 A CN 1110150A CN 94103391 A CN94103391 A CN 94103391A CN 94103391 A CN94103391 A CN 94103391A CN 1110150 A CN1110150 A CN 1110150A
- Authority
- CN
- China
- Prior art keywords
- water
- decocting
- extract
- fructus forsythiae
- fel ursi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 241000218202 Coptis Species 0.000 title claims description 11
- 235000002991 Coptis groenlandica Nutrition 0.000 title claims description 11
- 238000000034 method Methods 0.000 title abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 18
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 238000009835 boiling Methods 0.000 claims abstract description 6
- 239000008297 liquid dosage form Substances 0.000 claims abstract description 4
- 238000007127 saponification reaction Methods 0.000 claims abstract description 4
- 239000007909 solid dosage form Substances 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 15
- BHQCQFFYRZLCQQ-UTLSPDKDSA-N ursocholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-UTLSPDKDSA-N 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 9
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 8
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 8
- 229960003321 baicalin Drugs 0.000 claims description 8
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000000341 volatile oil Substances 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 241000555712 Forsythia Species 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000003916 acid precipitation Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000000413 hydrolysate Substances 0.000 claims description 2
- 238000001990 intravenous administration Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 4
- 206010010904 Convulsion Diseases 0.000 abstract description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 3
- 230000036461 convulsion Effects 0.000 abstract description 3
- 208000026435 phlegm Diseases 0.000 abstract description 3
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 239000009254 shuang-huang-lian Substances 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 241001482588 Naemorhedus goral Species 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- 238000001914 filtration Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 238000013019 agitation Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 239000008215 water for injection Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000013505 freshwater Substances 0.000 description 3
- 230000018199 S phase Effects 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94103391A CN1060050C (zh) | 1994-04-05 | 1994-04-05 | 一种加味双黄连药剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94103391A CN1060050C (zh) | 1994-04-05 | 1994-04-05 | 一种加味双黄连药剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1110150A true CN1110150A (zh) | 1995-10-18 |
CN1060050C CN1060050C (zh) | 2001-01-03 |
Family
ID=5031046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94103391A Expired - Lifetime CN1060050C (zh) | 1994-04-05 | 1994-04-05 | 一种加味双黄连药剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1060050C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890048B (zh) * | 2009-05-21 | 2013-12-04 | 上海凯宝药业股份有限公司 | 一种熊胆粉总胆酸提取物及其注射剂的制备方法和用途 |
CN104814925A (zh) * | 2015-05-20 | 2015-08-05 | 上海凯宝药业股份有限公司 | 一种清热化痰口服液及其制备方法 |
CN105395616A (zh) * | 2013-12-02 | 2016-03-16 | 李兴惠 | 用于清热化痰解毒的注射液 |
CN105687327A (zh) * | 2014-11-25 | 2016-06-22 | 哈药集团中药二厂 | 一种治疗腺样体肥大及鼻息肉的中药组合物及其制备方法和应用 |
CN114432365A (zh) * | 2021-12-30 | 2022-05-06 | 上海凯宝药业股份有限公司 | 一种痰热清雾化吸入制剂及其应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784203A (zh) * | 2011-05-20 | 2012-11-21 | 上海凯宝药业股份有限公司 | 一种痰热清片剂及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1023375C (zh) * | 1989-11-11 | 1994-01-05 | 黑龙江中医学院 | 双黄连粉针剂制备工艺 |
-
1994
- 1994-04-05 CN CN94103391A patent/CN1060050C/zh not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890048B (zh) * | 2009-05-21 | 2013-12-04 | 上海凯宝药业股份有限公司 | 一种熊胆粉总胆酸提取物及其注射剂的制备方法和用途 |
CN105395616A (zh) * | 2013-12-02 | 2016-03-16 | 李兴惠 | 用于清热化痰解毒的注射液 |
CN105687327A (zh) * | 2014-11-25 | 2016-06-22 | 哈药集团中药二厂 | 一种治疗腺样体肥大及鼻息肉的中药组合物及其制备方法和应用 |
CN104814925A (zh) * | 2015-05-20 | 2015-08-05 | 上海凯宝药业股份有限公司 | 一种清热化痰口服液及其制备方法 |
CN114432365A (zh) * | 2021-12-30 | 2022-05-06 | 上海凯宝药业股份有限公司 | 一种痰热清雾化吸入制剂及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1060050C (zh) | 2001-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101711825A (zh) | 法半夏的炮制方法 | |
CN1947746B (zh) | 一种祛痰清热的药剂及其制备方法 | |
CN1060050C (zh) | 一种加味双黄连药剂及其制备方法 | |
CN103006914A (zh) | 一种兽用板青颗粒及其制备方法 | |
CN105399795B (zh) | 一种从黄芪中提取黄芪甲苷的方法 | |
CN102319354B (zh) | 清热解毒口服液及其制备方法 | |
CN102614457B (zh) | 一种乳康片的制备方法 | |
CN102429994B (zh) | 一种复方鱼腥草合剂及其制备方法 | |
CN1201756C (zh) | 一种治疗咽炎的药品雾化液的制作工艺 | |
CN109045153A (zh) | 一种植物药材提取液及其制备方法 | |
CN101530474A (zh) | 一种复方芩兰口服液 | |
CN100531714C (zh) | 用于生产浓缩型双黄连口服液的制备方法 | |
CN1194700C (zh) | 金莲花粉针剂及其制备方法 | |
CN1267665A (zh) | 高效止血原料药三七素的制备方法 | |
CN1044760A (zh) | 双黄连粉针剂制备工艺 | |
CN101869675A (zh) | 一种治疗暑湿感冒的中药组合物颗粒剂及其制备方法 | |
CN1331512C (zh) | 祛痰平喘合剂及其制备方法 | |
CN110934897A (zh) | 一种治疗脑血管疾病后遗症的药物的制备方法 | |
CN100479804C (zh) | 藏药独一味注射制剂及其制备方法 | |
CN1317007C (zh) | 一种珍珠解毒口服液及制备方法 | |
CN102101892A (zh) | 从紫锥菊中提取多糖的方法 | |
CN1628747B (zh) | 一种治疗急性热病的药物及其制备方法 | |
CN102526107B (zh) | 一种熊胆提取物、制备方法及其在制备治疗烫伤药物中的应用 | |
CN1025109C (zh) | 苦、桂全素注射剂的制造方法 | |
CN1062468C (zh) | 鸡胆口服液及其制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CAO CHUNLIN; SHANGHAI KAIBAO PHARMACEUTICAL CO., Free format text: FORMER OWNER: CAO CHUNLIN Effective date: 20060707 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060707 Address after: 100015, Beijing, Chaoyang District Sun Palace Township Cross 85 Co-patentee after: Shanghai Kaibao Pharmaceutical Co., Ltd. Patentee after: Cao Chunlin Address before: 100015, Beijing, Chaoyang District Sun Palace Township Cross 85 Patentee before: Cao Chunlin |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Cross section 85, Taiyanggong Township, Chaoyang District, Beijing, zip code: 100015 Co-patentee after: Shanghai Kaibao Pharmaceutical Co., Ltd. Patentee after: Cao Chun Lin Address before: Cross section 85, Taiyanggong Township, Chaoyang District, Beijing, zip code: 100015 Co-patentee before: Shanghai Kaibao Pharmaceutical Co., Ltd. Patentee before: Cao Chun Lin |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20140405 Granted publication date: 20010103 |